46 related articles for article (PubMed ID: 36650997)
1. Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors.
Cieślak M; Danel T; Krzysztyńska-Kuleta O; Kalinowska-Tłuścik J
Sci Rep; 2024 Apr; 14(1):8228. PubMed ID: 38589405
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of 2-Azolylmethylene-3-(2H)-benzofuranone Derivatives as Potent Monoamine Oxidases Inhibitors.
Takao K; Kubota Y; Kurosaki K; Kamauchi H; Uesawa Y; Sugita Y
Chem Pharm Bull (Tokyo); 2024; 72(1):109-120. PubMed ID: 38267058
[TBL] [Abstract][Full Text] [Related]
3. Docking, Synthesis, and I
Muthukumaran T; Kumar KA; Francis MS
Curr Comput Aided Drug Des; 2024; 20(5):431-440. PubMed ID: 37231754
[TBL] [Abstract][Full Text] [Related]
4. Multistage
Gupta S; Saha M; Singh R; Ahmed SB; Asati V
J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38287494
[TBL] [Abstract][Full Text] [Related]
5. Correlation intensity index-index of ideality of correlation: A hyphenated target function for furtherance of MAO-B inhibitory activity assessment.
Bhawna ; Kumar S; Kumar P; Kumar A
Comput Biol Chem; 2024 Feb; 108():107975. PubMed ID: 37950961
[TBL] [Abstract][Full Text] [Related]
6.
Choudhary D; Kaur R; Rani N; Singh TG; Kumar B
Curr Comput Aided Drug Des; 2024; 20(5):711-722. PubMed ID: 37815181
[TBL] [Abstract][Full Text] [Related]
7. Investigation of 3-Phenylcoumarin Derivatives as Potential Multi-target Inhibitors for Human Cholinesterases and Monoamine oxidases: A Computational Approach.
Fayyaz A; Ejaz SA; Alsfouk BA; Ejaz SR
Appl Biochem Biotechnol; 2024 Jun; ():. PubMed ID: 38874841
[TBL] [Abstract][Full Text] [Related]
8. Filtration of Natural Derivatives as MAO Inhibitors by Virtual Screening: A Potential Lead for Neurodegenerative Disorders.
Malik N; Agnihotri S; Dhiman P
Cent Nerv Syst Agents Med Chem; 2024 Apr; ():. PubMed ID: 38584543
[TBL] [Abstract][Full Text] [Related]
9. Development of novel chromones as antioxidant COX2 inhibitors:
Lakkadi A; Vuppala S; Nampally V; Kim J; Kim K; Jang J; Tigulla P
J Biomol Struct Dyn; 2024 Apr; 42(6):2793-2808. PubMed ID: 37184132
[TBL] [Abstract][Full Text] [Related]
10. Chromone-isoxazole hybrids molecules: synthesis, spectroscopic, MEDT, ELF, antibacterial, ADME-Tox, molecular docking and MD simulation investigations.
Kanzouai Y; Laghmari M; Yamari I; Bouzammit R; Bahsis L; Benali T; Chtita S; Bakhouch M; Akhazzane M; El Kouali M; Hammani K; Al Houari G
J Biomol Struct Dyn; 2024 Aug; 42(12):6410-6424. PubMed ID: 37817499
[TBL] [Abstract][Full Text] [Related]
11. Investigating the potential of 6-substituted 3-formyl chromone derivatives as anti-diabetic agents using in silico methods.
Saif MZ; Esha NJI; Quayum ST; Rahman S; Al-Gawati MA; Alsowygh G; Albrithen H; Alodhayb AN; Poirier RA; Uddin KM
Sci Rep; 2024 Jun; 14(1):13221. PubMed ID: 38851807
[TBL] [Abstract][Full Text] [Related]
12. Exploring
Zia M; Parveen S; Shafiq N; Rashid M; Farooq A; Dauelbait M; Shahab M; Salamatullah AM; Brogi S; Bourhia M
ACS Omega; 2024 Jan; 9(2):2161-2182. PubMed ID: 38250382
[TBL] [Abstract][Full Text] [Related]
13. A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression.
Margret AA; Begum TN; Parthasarathy S; Suvaithenamudhan S
Nat Prod Bioprospect; 2015 Dec; 5(6):293-306. PubMed ID: 26667936
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Protein-compound Binding Energies from Known Activity Data: Docking-score-based Method and its Applications.
Fukunishi Y; Yamashita Y; Mashimo T; Nakamura H
Mol Inform; 2018 Jul; 37(6-7):e1700120. PubMed ID: 29442436
[TBL] [Abstract][Full Text] [Related]
15. Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma.
Sugita Y; Takao K; Uesawa Y; Nagai J; Iijima Y; Sano M; Sakagami H
Medicines (Basel); 2020 Aug; 7(9):. PubMed ID: 32858984
[TBL] [Abstract][Full Text] [Related]
16. Insilico design of an allosteric modulator targeting the protein-protein interaction site of 3 Phosphoinositide dependent Kinase-1: design, synthesis and biological activity.
Kailasam Natesan V; Balaraman S; KuppannaGounder Pitchaimuthu E
In Silico Pharmacol; 2023; 11(1):26. PubMed ID: 37767119
[TBL] [Abstract][Full Text] [Related]
17. Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach.
Baweja GS; Gupta S; Kumar B; Patel P; Asati V
Mol Divers; 2023 Mar; ():1-23. PubMed ID: 36977955
[TBL] [Abstract][Full Text] [Related]
18. Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors.
Saha M; Gupta S; Dhiman S; Asati V; Ali A; Ali A
J Biomol Struct Dyn; 2023; 41(21):12171-12185. PubMed ID: 36650997
[TBL] [Abstract][Full Text] [Related]
19. Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation.
Kumar S; Jayan J; Manoharan A; Benny F; Abdelgawad MA; Ghoneim MM; El-Sherbiny M; Thazhathuveedu Sudevan S; Aneesh TP; Mathew B
J Biomol Struct Dyn; 2024 Mar; 42(5):2328-2340. PubMed ID: 37261844
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
